×
How AI detects the hidden diseases doctors aren’t looking for
Written by
Published on
Join our daily newsletter for breaking news, product launches and deals, research breakdowns, and other industry-leading AI coverage
Join Now

AI-powered opportunistic screening technology is enabling healthcare providers to detect undiagnosed diseases by analyzing routine CT scans and other medical imaging for conditions beyond their original purpose.

The breakthrough case: Will Studholme’s emergency room visit for food poisoning led to an unexpected osteoporosis diagnosis after AI technology analyzed his routine abdominal CT scan and identified a collapsed vertebra.

  • The 58-year-old male patient would likely have gone undiagnosed without the AI screening, as he didn’t fit the typical osteoporosis patient profile
  • The early detection enabled doctors to begin preventative treatment with annual drug infusions to improve bone density

How the technology works: Artificial intelligence algorithms are trained on thousands of tagged medical scans to identify early indicators of various diseases that human radiologists might miss during routine examinations.

  • The AI systematically analyzes imaging data that often goes unused, looking for signs of conditions like osteoporosis, heart disease, fatty liver disease, and diabetes
  • The technology is designed to complement human expertise, with radiologists reviewing AI findings before they’re reported to doctors
  • Training data must include diverse ethnic groups to ensure the technology works effectively across populations

Implementation and results: Oxford NHS hospitals have been at the forefront of implementing this technology, particularly for osteoporosis screening.

  • Since officially adopting Nanox.AI’s osteoporosis screening tool in 2020, Oxford hospitals have seen up to a six-fold increase in identifying patients with vertebral fractures
  • The success has led to expanded trials at hospitals in Cambridge, Cardiff, Nottingham and Southampton
  • The technology is being developed by only a handful of companies, with Nanox.AI offering products for screening osteoporosis, heart disease, and fatty liver disease

Healthcare system impacts: While the technology shows promise for early disease detection, it presents challenges for healthcare system resources.

  • The increased identification of potential conditions requires additional confirmatory testing and follow-up care
  • Healthcare providers must adapt their systems to handle the increased patient load, such as Oxford’s nurse-delivered fracture prevention service
  • Despite initial resource strain, early detection and prevention could lead to long-term cost savings, particularly for conditions like osteoporosis where complications often result in hospitalization

Future implications: The emerging field of AI-powered opportunistic screening represents a shift toward more proactive healthcare, though careful consideration of healthcare system capacity and resource allocation will be crucial for successful implementation.

  • Healthcare providers will need to balance the benefits of early detection against the strain on resources and potential for unnecessary testing
  • The technology could help reduce healthcare disparities by screening all patients regardless of demographic profiles
  • Success will depend on developing efficient pathways for handling increased diagnosis rates and ensuring appropriate follow-up care
How AI can spot diseases that doctors aren't looking for

Recent News

Apple pulled its hallucinating AI summaries, but improvement (and patience) should be expected

Apple temporarily disables AI news summaries in iOS beta after system generated false reports about deaths and sports results.

Introducing the WeirdML Benchmark: A novel way to tests AI models on unusual tasks

A suite of unusual tests evaluates how AI systems handle tasks beyond standard benchmarks, from interpreting poetry to solving riddles.

AI talent exodus threatens academic research future

Researchers find simpler AI training methods can rival complex ones, potentially lowering barriers to entry for smaller organizations.